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he de novo formation of basal bodies in 
 
Naegleria
gruberi
 
 was preceded by the transient formation
of a microtubule (MT)-nucleating complex contain-
ing 
 
 
 
-tubulin, pericentrin, and myosin II complex (GPM
complex). The MT-nucleating activity of GPM complexes
was maximal just before the formation of visible basal
bodies and then rapidly decreased. The regulation of
MT-nucleating activity of GPM complexes was accom-
plished by a transient phosphorylation of the complex.
Inhibition of dephosphorylation after the formation of
T
 
basal bodies resulted in the formation of multiple ﬂagella.
2D-gel electrophoresis and Western blotting showed a
parallel relationship between the MT-nucleating activity
of GPM complexes and the presence of hyperphosphor-
ylated 
 
 
 
-tubulin in the complexes. These data suggest
that the nucleation of MTs by GPM complexes precedes
the de novo formation of basal bodies and that the reg-
ulation of MT-nucleating activity of GPM complexes is
essential to the regulation of basal body number.
 
Introduction
 
We have been using the differentiation of 
 
Naegleria gruberi
 
amoebae into swimming flagellates as a model system to ex-
plore the mechanism of de novo basal body formation. We
noticed that the initial events that occur during de novo basal
body formation in 
 
N. gruberi
 
 (Suh et al., 2002) are very similar
to the events during de novo formation of centrosomes in CHO
cells (Khodjakov et al., 2002). First, 
 
 
 
-tubulin and pericentrin
are concentrated at a discrete “spot” before the formation of
centrioles (or basal bodies) in both systems. Second, the con-
centration of 
 
 
 
-tubulin is accomplished without the formation
of microtubules (MTs); and third, centrioles (or basal bodies)
are formed at the site of the 
 
 
 
-tubulin concentration. These
similarities suggested to us that the formation of a protein com-
plex containing 
 
 
 
-tubulin and pericentrin might be a common
event in the de novo formation of centrioles and basal bodies.
Based on these ideas, we developed biochemical proce-
dures for the purification of 
 
 
 
-tubulin–containing complexes
from 
 
N. gruberi
 
 and examined the possible role of these com-
plexes in the formation of basal bodies. In this report, we present
evidence that: (a) a protein complex containing 
 
 
 
-tubulin, peri-
centrin, and myosin II complex (GPM complex) is transiently
formed during the differentiation; (b) in vitro nucleation of MT
by this complex is dependent on 
 
 
 
-tubulin; (c) the MT-nucleating
activity of GPM complexes is tightly regulated during basal
body formation by phosphorylation; (d) inhibition of the regu-
lation resulted in the formation of multiple flagella; and (e)
 
 
 
-tubulin is one of the targets for the phosphorylation.
 
Results and discussion
 
Identification of a protein complex 
containing 
 
 
 
-tubulin and pericentrin
 
We prepared 
 
N. gruberi
 
 extracts from cells at 40 min after initi-
ation of the differentiation when the percentage of cells with a
concentrated spot of 
 
 
 
-tubulin was maximal (Suh et al., 2002).
We fractionated the extracts by density-gradient centrifugation.
After Western blotting with anti–
 
 
 
-tubulin Ab, the fractions
were pooled into three groups; group 1 (fractions that sedi-
mented faster than the 
 
 
 
-tubulin–containing fractions), group 2
(
 
 
 
-tubulin–containing fractions), and group 3 (fractions that
sedimented more slowly than the 
 
 
 
-tubulin–containing fractions).
The 
 
 
 
-tubulin in the group 2 fractions was present in 1–3-
 
 
 
m
particles (Fig. 1 A). Pericentrin was present in the same particles
(Fig. 1 B). The presence of 
 
 
 
-tubulin in the complex was further
supported by a competition assay using 
 
Naegleria
 
-
 
 
 
-tubulin
(GenBank/EMBL/DDBL accession no. AY919610) synthesized
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in 
 
E. coli
 
 as an MBP-fusion protein (MBP-N-
 
 
 
Tub; Fig. S1,
available at http://www.jcb.org/cgi/content/full/jcb.200410052/
DC1). Additional studies with anti–myosin II Ab showed that
the group 2 complexes also contained myosin II (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200410052/
DC1). We named these complexes GPM complexes (
 
 
 
-tubulin,
pericentrin, and myosin II complexes). These complexes were
not found in group 1 or group 3 fractions.
 
In vitro MT nucleation from 
GPM complexes
 
GPM complexes were capable of nucleating MTs in vitro
 
,
 
 Fig.
1 C. Preincubation with anti–
 
 
 
-tubulin Ab inhibited the forma-
tion of MTs from the complexes, Fig. 1 D, although 
 
 
 
-tubu-
lin remained in the complexes after preincubation with anti–
 
 
 
-tubulin Ab. Preincubation with nonspecific Abs (anti–rabbit
IgG Ab or anti–mouse IgG Ab) or addition of anti–
 
 
 
-tubulin
Ab preincubated with MBP-N-
 
 
 
Tub had no effect on the for-
mation of MTs from GPM complexes (unpublished data).
These data suggest that access to 
 
 
 
-tubulin is required for the in
vitro nucleation of MTs from the GPM complexes and that the
formation of MTs is not the result of the elongation of prenu-
cleated MTs in the complex.
 
Changes in the MT-nucleating activity of 
GPM complexes during the differentiation
 
The transient concentration of 
 
 
 
-tubulin during the differentia-
tion persists such that 
 
 
 
30% of cells still have a concentrated
 
 
 
-tubulin spot at 80 min after the initiation of differentiation,
when 
 
 
 
80% of cells already have a pair of elongated flagella.
In these cells, the 
 
 
 
-tubulin concentration was located at the
opposite end of the cell from the flagella and had no MTs asso-
ciated with it (see Fig. 4 A; Suh et al., 2002). These data sug-
gested that the region of 
 
 
 
-tubulin concentration had lost its
MT-nucleating activity after the formation of basal bodies and
that the MT-nucleating activity of GPM complex is regulated
during the differentiation.
Fig. 2 illustrates the differences in the MT-nucleating ac-
tivities of GPM complexes prepared before (20 and 40 min;
GPM20 and 40 complexes) and after (60 and 80 min; GPM60
and 80 complexes) basal body formation. Although particles
from 20 and 80 min cells contain 
 
 
 
-tubulin, they did not nucleate
MT. Numerous MTs formed from all of the GPM40 complexes.
In contrast only 
 
 
 
20% of GPM60 complexes were able to nucle-
ate MTs and the number of MTs nucleated from these complexes
was significantly decreased based on the intensity of the fluores-
cence. These data demonstrate that the MT-nucleating activity of
GPM complexes is maximal at 40 min, just before the appear-
Figure 1. GPM complexes nucleate MTs in vitro. (A) A
N. gruberi extract was prepared from cells at 40 min af-
ter initiation of differentiation and fractionated by a su-
crose-density gradient centrifugation. After Western
blotting with anti– -tubulin Ab, the fractions were
pooled into three groups based on the  -tubulin content,
see text. 15  l of each group was transferred onto a
round coverslip and stained with monoclonal anti– -tubu-
lin Ab (1:500) and Texas red–conjugated anti–mouse-
IgG (1:100) second Ab. After observation under DIC
optics, the same field was examined under fluorescent
optics. Arrows in DIC images indicate the protein com-
plexes. (B) 15  l of the group 2 extract were transferred
onto a round coverslip and stained with rabbit poly-
clonal anti-pericentrin Ab (1:500) and monoclonal anti–
 -tubulin Ab (1:500). Pericentrin (FITC) and  -tubulin
(Texas red) were visualized with respective second Ab.
Arrows in DIC images indicate the protein complexes.
(C) MT nucleation was performed using rhodamine-tubu-
lin as described in Materials and methods. The presence
of  -tubulin in the GPM complexes was visualized with
anti– -tubulin Ab and FITC-conjugated second Ab. (D) A
group 2 extract was preincubated with polyclonal anti– -tubulin Ab (1:500) for 20 min at RT and used for MT-nucleation with rhodamine-tubulin at
30 C. The presence of  -tubulin was visualized with FITC-conjugated anti–rabbit IgG Ab. Bars, 10  m.
Figure 2. The MT-nucleating activity of GPM complexes changes during
the differentiation. (Left and middle) GPM complexes were prepared from
cells at 20, 40, 60, and 80 min after initiation of differentiation and incu-
bated with anti– -tubulin Ab and Texas red–conjugated second Ab and ex-
amined under DIC (left) and epifluorescence ( -tubulin) optics as described
in Fig. 1 A. GPM complexes (arrows) from different stages of the differenti-
ation contain  -tubulin. (Right) In vitro MT-nucleation was performed with
GPM complexes from 20, 40, 60, and 80 min cells with rhodamine-tubulin
and observed under an epifluorescence microscope. Bar, 10  m. 
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ance of visible basal bodies and that the activity decreases rap-
idly after this point. It is also apparent that the diameter of GPM
complex decreased by 80 min. The decrease both in the diameter
and the intensity of 
 
 
 
-tubulin Ab staining of GPM80 complexes
suggests that GPM complexes are being disassembled at this
stage of the differentiation (Fig. 3 D; Suh et al., 2002).
 
Regulation of MT-nucleating activity of 
GPM complexes by phosphorylation
 
Phosphatase-treated GPM40 complexes still contained 
 
 
 
-tubu-
lin but completely lost their MT-nucleating activity (Fig. 3 A).
The inactivation of GPM40 complexes by phosphatase was not
observed when phosphatase inhibitors (PI; final concentrations;
1 mM 
 
o
 
-vanadate, 5 mM NaF, and 20 mM 
 
 
 
-glycerophosphate)
were added to GPM40 complexes before the phosphatase treat-
ment (unpublished data). These data suggest that the observed
inactivation of GPM complexes after the formation of basal
bodies might be the result of dephosphorylation of one or more
components. To test this hypothesis, we added PI to differenti-
ating cells at 50 min after initiation of the differentiation a time
when the MT-nucleating activity of GPM complexes might be
expected to begin to be inactivated (Fulton, 1977; Walsh,
1984). PI had a very limited effect on the formation of flagella.
At the end of differentiation 83% of the cells had visible flagella
(Fig. 3 B). However, the inhibitor had a noticeable effect on the
number of cells with multiple flagella (Table I). At the end of
differentiation, 
 
 
 
23% of the PI-treated cells formed multiple
flagella. On the contrary, 
 
 
 
4% of flagellated cells in the control
had more than one pair of flagella. PI treatment had no effect ei-
ther on the transient accumulation of 
 
 
 
-tubulin mRNA or on the
synthesis of the tubulin (unpublished data).
These data suggested that the formation of multiple fla-
gella was a result of continuous MT-nucleation from GPM
complexes that were not dephosphorylated due to the inhibitor
treatment. This conclusion is supported by two experiments.
First, we performed in vitro MT-nucleation assays with GPM
Figure 3. The effects of phosphatase or PIs
on the activity of GPM complexes. (A) GPM40
complexes were treated with phosphatase for
30 min and used for a MT nucleation assay.
The phosphatase-treated complexes still con-
tained  -tubulin but completely lost MT-nucle-
ation activity. (B) N. gruberi amoebae were
induced to differentiate. At 50 min after the
initiation of differentiation, PI were added.
Closed circle, control differentiation; open cir-
cle, PI treated; arrow, the time of PI addition.
(C) Cell differentiation and PI treatment were
performed as described in B. GPM complexes
were prepared at 80 min after initiation from
control (GPM80-C) and PI-treated cells
(GPM80-PI). A portion of each sample was in-
cubated with anti– -tubulin Ab and Texas red–
conjugated second Ab and observed under
DIC or epifluorescence microscope to confirm
the presence of  -tubulin–containing com-
plexes (left and middle). The remaining portion
of each sample was used for MT-nucleation
assay with rhodamine-tubulin and observed under epifluorescence microscope (right). (D) Cell differentiation and PI treatment were performed as described
in B. Cells were taken at 20-min intervals, fixed, and immunostained with anti– -tubulin Ab and Texas red–conjugated second Ab. At each time point,
100 cells were examined at random and scored for the presence of a concentrated  -tubulin spot. Closed circle, control differentiation; open circle, PI
treated; arrow, the time of PI addition. Bar, 10  m.
 
Table I. 
 
Phosphatase inhibitors induce the production of multiple flagella
Phosphatase inhibitor Control
Time (min) a b c d a b c d
 
0 0 000 00 0 0
4 0 0 000 00 0 0
60 17 
 
 
 
 0.7 2.3 
 
 
 
 0.2 0 15 
 
 
 
 2.7 13 
 
 
 
 0.7 0 0 0
80 52.3 
 
 
 
 1.6 10 
 
 
 
 0.7 0.7 
 
 
 
 0.2 18.2 
 
 
 
 0.9 76.7 
 
 
 
 0.2 1.3 
 
 
 
 0.1 0 1.7 
 
 
 
 0.3
100 59.3 
 
 
 
 2.9 13.3 
 
 
 
 0.2 1.6 
 
  0.2 20.8   0.3 88.3   0.9 2.3   0.2 0 2.6   0.2
120 64   0.7 16.3   0.7 2.3   0.2 22.5   0.5 95.3   0.9 3.3   0.2 0 3.4   0.3
N. gruberi amoebae were divided into two flasks and differentiated at the same time. At 50 min after initiation, PI were added into one of the flasks. At 20-min intervals,
200  l of differentiating cells were taken, fixed with Lugol’s iodine, and observed under phase contrast optics. The percentage of flagellated cells and the number of
flagella per flagellated cell were determined by randomly counting 100 cells at each time point. The numbers in Table I are the average of three independent
experiments.
aThe percentage of cells with one pair of flagella.
bThe percentage of cells with two pairs of flagella.
cThe percentage of cells with three (or more) pairs of flagella
dThe percentage of cells with excess flagella (b   c)/(a   b   c).JCB • VOLUME 169 • NUMBER 5 • 2005 722
complexes prepared from PI-treated cells. PI were added to
differentiating cells at 50 min after initiation and GPM com-
plexes were prepared at 80 min. Fig. 3 C shows that GPM80
complexes prepared from the inhibitor-treated cells were still
capable of nucleating MTs, whereas GPM80 complexes from
control cells had lost this activity. Second, we examined the
effect of PI on the formation of GPM complexes and on MT-
nucleation from the complexes by immunostaining the differ-
entiating cells. PI treatment significantly delayed the disap-
pearance of the  -tubulin spot (Fig. 3 D). In control cells, the
presence of a concentrated spot of  -tubulin peaked at 40 min
(60%) than decreased rapidly as reported previously (Suh et
al., 2002). In contrast,  40% of PI-treated cells still had a
concentrated spot of  -tubulin at 120 min. These data suggest
that dephosphorylation is also involved in the disassembly of
GPM complexes.
Fig. 4 A shows a control cell fixed at 80 min after initia-
tion of differentiation. This cell has a pair of flagella and a
heavy concentration of  -tubulin at the base of flagella (basal
bodies). This cell also contains a concentrated spot of  -tubulin
(Suh et al., 2002) but the  -tubulin spot is not detected with
anti– -tubulin Ab suggesting that it is not capable of nucleat-
ing MT. Fig. 4 B shows cells fixed at 80 min that were treated
with PI at 50 min. Many of these cells contain a concentrated
spot of  -tubulin that is also recognized by anti– -tubulin Ab
suggesting the presence of a GPM complex capable of nucleat-
ing MT. In some cells an extra pair of flagella is seen emanat-
ing from the GPM complex.
A parallel relationship between the MT-
nucleating activity and phosphorylation 
of  -tubulin in GPM complexes
It has been reported that the phosphorylation of  -tubulin plays
important roles in MT nucleation from the spindle pole body of
Saccharomyces cerevisiae (Vogel et al., 2001). Based on this
observation, we examined the possible phosphorylation of the
 -tubulin in GPM complexes. GPM40 complexes contained
four differently modified  -tubulins, Fig. 5 A (spots 1 to 4 indi-
cated by red, blue, gray, and black arrows, respectively; from
acidic to basic side of the gel). After phosphatase treatment of
isolated GPM40 complexes, the three acidic forms of  -tubulin
were not detected. Only the most basic form of  -tubulin (spot 4)
was found (Fig. 5 A). This change was not observed when PI
were present in the reaction (not depicted). 2D-gel electro-
phoresis and Western blotting with anti– -tubulin Ab of GPM
complexes prepared from cells at 20, 40, 60, and 80 min after
the initiation of differentiation showed that there is a parallel
relationship between the change in MT-nucleating activities of
GPM complexes from different stages of differentiation and
the degree of phosphorylation of  -tubulin in these complexes
(Fig. 2 and Fig. 5 B).
Our data demonstrate that de novo formation of basal bod-
ies in N. gruberi is preceded by the formation of a protein com-
plex (GPM complex) that contains two well-known components
of pericentriolar material ( -tubulin and pericentrin). GPM
complexes acquire their MT-nucleating activity around 40 min
Figure 4. Phosphatase inhibitor treatment induced the formation of
multiple flagella. Cells were taken at 80 min after initiation, fixed, and im-
munostained with rabbit polyclonal anti– -tubulin Ab and monoclonal
anti– -tubulin Ab. GPM complexes (Texas red) and MTs (FITC) were vi-
sualized by respective second Ab. (A) Control cells. (B) PI-treated cells.
Arrows indicate flagella. Closed arrowheads indicate GPM complexes
recognized by anti– -tubulin Ab. Open arrowheads indicate GPM com-
plexes recognized by both anti– -tubulin and anti– -tubulin Ab. Bar, 10  m.
Figure 5. Hyperphosphorylated   -tubulin
in GPM40 complexes. (A) GPM40 complexes
were prepared as described in Materials and
methods. After 2D-gel electrophoresis,
Western blots were performed with anti–
 -tubulin Ab. The background spots that were
detected with the second Ab alone were
used as internal markers to align  -tubulin
spots. Control: GPM40 complexes without
phosphatase treatment. PPase: GPM40 com-
plexes treated with phosphatase. (B) GPM
complexes were prepared at 20, 40, 60,
and 80 min after initiation of the differenti-
ation. After 2D-gel electrophoresis and
Western blotting with anti– -tubulin Ab,
 -tubulin spots were aligned as described
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after initiation of the differentiation just before the appearance
of visible basal bodies (Fulton, 1977; Walsh, 1984; Suh et al.,
2002). After the formation of basal bodies, the GPM complexes
lose MT-nucleating activity and are no longer detected by anti–
 -tubulin Ab suggesting the disassembly of the complexes.
Combined with our in vitro data, the formation of extra
pairs of flagella in PI-treated cells (Table I and Fig. 5)
strongly suggest that MT-nucleation from GPM complexes is
essential for the de novo formation of basal bodies and that
the GPM complexes are the site of de novo basal body assembly.
Our data also suggest that the inactivation of GPM complex
after basal body formation is involved in regulating the num-
ber of basal bodies per cell. This hypothesis is supported by
recent studies (Marshall et al., 2001; Khodjakov et al., 2002;
Wong and Stearns, 2003; La Terra et al., 2005) that suggest
the presence of a centriole inhibits the unregulated assembly
of new centrioles.
The phosphorylation of  -tubulin in GPM complexes is
correlated with the MT-nucleating activity of the complex. In
Saccharomyces cerevisiae, Vogel et al. (2001) showed that
phosphorylated Tub4p had an augmented activity in MT as-
sembly and suggested that the phosphorylation of Tub4p in G1
phase might be related to the replication of the spindle pole
body. The similar effect of  -tubulin phosphorylation on MT
formation observed in budding yeast and N. gruberi suggests
the presence of a similar mechanism in other organisms.
Materials and methods
Growth and differentiation of N. gruberi
Growth and differentiation of N. gruberi NB-1 has been described else-
where (Fulton, 1977; Walsh, 1984; Suh et al., 2002). For PI treatment, a
stock solution of a PI cocktail was added at 50 min after initiation of differ-
entiation (final concentrations; 1 mM o-vanadate, 5 mM NaF, and 20 mM
 -glycerophosphate; Vogel et al., 2001).
Preparation of Naegleria extracts and partial purification of GPM complexes
Cells ( 4   10
8) were harvested by centrifugation at different stages of
differentiation. The cell pellet was resuspended in 2 vol of cold amoeba
extraction buffer (25 mM Hepes, pH 6.8, 50 mM KCl, 1 mM MgCl2, 1 mM
DTT, 250 mM sucrose) containing 0.5 mM benzamine-HCl and 10  g/ml
each of aprotinin, leupeptin, and pepstatin A (Wilhelm et al., 2000). Cells
were lysed by three cycles of freezing and thawing. The cell lysate was
centrifuged at 11,000 g for 15 min at 4 C. The supernatant was collected
and recentrifuged as above. The supernatant from the second centrifugation
was stored at  80 C for further study. Naegleria extract (700  l) was
mixed with 300  l of sucrose-free amoeba extraction buffer and applied
to a 10–40% sucrose step gradient (seven 1.4-ml steps). Centrifugation
was performed using a SW 41 rotor (Beckman Instruments) at 100,000 g
for 16 h.
Antibodies
Two anti– -tubulin Abs were purchased from Sigma-Aldrich (T-3599, poly-
clonal; T6557, monoclonal). Polyclonal antiserum against Dictyostelium
myosin II heavy chain was raised in rabbits (Yumura, 1994). mAb against
 -tubulin was purchased from Sigma-Aldrich (T5168). pAb against peri-
centrin was purchased from Babco. Second antibodies were purchased
from Santa Cruz Biotechnology, Inc.: Texas red anti–rabbit IgG (sc-2780),
Texas red anti–mouse IgG (sc-2781), FITC-anti–rabbit IgG (sc-2012), and
FITC-anti–mouse IgG (sc-2010).
In vitro MT nucleation from GPM complexes
In vitro MT nucleation was performed using the method of Moritz and Al-
berts (1999) with modifications. 20  l of free tubulin in TDB (2 mg/ml;
1:7 mixture of rhodamine-labeled tubulin and unlabeled tubulin; Cyto-
skeleton, Inc.) was mixed with 20  l of Naegleria extract (group 2) and
incubated for 10 min at 30 C. To fix the formed MTs, 240  l of 1% glu-
taraldehyde in BRB 80 was added to each tube and the tubes were incu-
bated at RT for 3 min. For detection of  -tubulin, pericentrin, or myosin II
in the complex, 20  l of each sample was applied to a round glass cov-
erslip (acid washed and coated with poly-D-lysine) and incubated for 10 min.
The coverslips were incubated in cold methanol ( 20 C) for 3 min and
washed with TBS. The coverslips were incubated in 0.1% sodium boro-
hydride in TBS for 7 min and transferred into blocking solution (3% BSA
in TBS). After 5 min, primary Ab was added to each coverslip. After 1 h,
the coverslips were washed and incubated for 1 h with desired second Ab.
After washing, all samples were mounted in Mowiol mounting solution
for microscopy. Buffers for in vitro MT-nucleation assay: BRB 80 (80 mM
K-Pipes, pH 6.8, 1 mM MgCl2, 1 mM Na3EGTA, prepared as a 5 
stock, diluted to 1  before use; Moritz and Alberts, 1999); GTP stock
(0.5 M GTP in 1  BRB 80); tubulin dilution buffer (TDB; 1  BRB 80,
10% glycerol, 1 mM GTP); and TDB washing buffer (TDB-containing BSA
[fraction V], 10 mg/ml).
Production of Naegleria  -tubulin in E. coli
We recently cloned a  -tubulin gene from N. gruberi (GenBank/EMBL/
DDBL accession no. AY919610). The deduced amino acid sequence of
the  Naegleria   -tubulin is 50–60% identical to  -tubulins from various
other species. Naegleria  -tubulin contains a conserved NH2-terminal pep-
tide sequence used to raise the antibody that was used in this study (aa
38–53 of human  -tubulin, EEFATEGTDRKDVFFY; aa 38–54 of Naegleria
 -tubulin, EDFAIQGAGDRKDVFFY). We expressed the NH2-terminal half
(aa 1–249) of Naegleria  -tubulin in E. coli as an MBP-fusion protein
(MBP-N- Tub).
Microscopy
Examinations by differential interference contrast and epifluorescence mi-
croscopy were performed at ambient temperature with an Axioplan 2 mul-
tipurpose microscope with 63  magnification, Plan-Neofluar 1.25 objec-
tive, Axio Cam, and AxioVision 3.1 software (all purchased from Carl
Zeiss MicroImaging, Inc.). All images were imported into Adobe Photo-
shop 6.0 for contrast manipulation and figure assembly.
Online supplemental material
Fig. S1 shows the presence of  -tubulin in GPM complex: a competition
assay. Fig. S2 shows the presence of myosin II in GPM complex. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200410052/DC1.
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